SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-089426
Filing Date
2015-03-12
Accepted
2015-03-12 17:09:02
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d857051d10k.htm 10-K 841444
2 EX-10.2.2 d857051dex1022.htm EX-10.2.2 76561
3 EX-10.11 d857051dex1011.htm EX-10.11 32439
4 EX-23.1 d857051dex231.htm EX-23.1 2799
5 EX-31.1 d857051dex311.htm EX-31.1 6087
6 EX-31.2 d857051dex312.htm EX-31.2 6175
7 EX-32.1 d857051dex321.htm EX-32.1 4186
14 GRAPHIC g857051g47r12.jpg GRAPHIC 113703
  Complete submission text file 0001193125-15-089426.txt   5466238

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT itci-20141231.xml EX-101.INS 632891
9 XBRL TAXONOMY EXTENSION SCHEMA itci-20141231.xsd EX-101.SCH 43924
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20141231_cal.xml EX-101.CAL 62169
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20141231_def.xml EX-101.DEF 131770
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20141231_lab.xml EX-101.LAB 387540
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20141231_pre.xml EX-101.PRE 263462
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36274 | Film No.: 15696728
SIC: 2834 Pharmaceutical Preparations